Determinants of asthma and its clinical courseBradley E Chipps
Capitol Allergy and Respiratory Disease Center, Sacramento, California, USA
Ann Allergy Asthma Immunol 93:309-15; quiz 315-8, 380. 2004
....
- Budesonide inhalation suspension reduces the need for emergency intervention in pediatric asthma: a named-patient case series
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
J Asthma 40:895-900. 2003
..In this case series, budesonide inhalation suspension represents a safe, effective treatment option to prevent recurrent emergency intervention for patients < 3 years of age with poorly controlled asthma...
- Asthma in infants and children
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
Clin Cornerstone 8:44-61. 2008
..Recent research efforts have focused on ways to improve inhalant drug delivery to the lungs and minimize oral and systemic bioavailability so as to improve the therapeutic benefit:risk ratio...
- Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
J Allergy Clin Immunol 119:1156-63. 2007
..Young patients with severe or difficult-to-treat asthma are an understudied population...
- Targeted interventions for difficult-to-treat asthma
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA
Expert Opin Ther Targets 11:11-20. 2007
..Newer and developing therapies that cater to specific types of asthmatic patients and may lead to improved outcomes in those patients for whom standard care is insufficient are also looked at...
- What are the determinates of asthma control?
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
J Asthma 43:567-72. 2006
....
- Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA
Allergy Asthma Proc 30:217-28. 2009
....
- Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, and University of Wisconsin, Madison, Wisconsin, USA
J Pediatr 148:517-21. 2006
..At baseline, all subjects met National Asthma Education and Prevention Program criteria for moderate/severe asthma...
- Assessment and treatment of acute asthma in children
Bradley E Chipps
Capital Allergy and Respiratory Disease Center, Sacramento, California, USA
J Pediatr 147:288-94. 2005
- Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study
June H Lee
Genentech, Inc, South San Francisco, California 94080, USA
J Asthma 43:179-84. 2006
....
- Office-based objective measures in childhood asthma
Joseph D Spahn
National Jewish Medical and Research Center, Denver, Colorado, USA
J Pediatr 148:11-5. 2006
- Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study
June H Lee
Genentech, Inc, 1 DNA Way, MS 453B, South San Francisco, CA 94080, USA
Chest 132:1882-9. 2007
..A better understanding is needed regarding factors associated with persistent airway obstruction; this study was performed to determine demographic and clinical characteristics associated with persistent airflow limitation...
- Dose counting and the use of pressurized metered-dose inhalers: running on empty
Nancy Sander
Allergy and Asthma Network Mothers of Asthmatics, Fairfax, Virginia, USA
Ann Allergy Asthma Immunol 97:34-8. 2006
..Given the necessity of a reliable dose counting method, it is clear that manufacturers should include dose counters as a standard feature of every metered-dose inhaler...
